Non Hodgkin Lymphoma Clinical Trial
Meaning-Centered Psychotherapy in Advanced Cancer
Summary
We have developed an 8-week Meaning-Centered Group Psychotherapy designed to help patients with advanced cancer sustain or enhance a sense of meaning, peace and purpose despite the limitations of their cancer illness. This project's overall aim is to explore the feasibility and efficacy of this new and unique psychotherapy intervention for advanced cancer patients in enhancing psychological and spiritual well-being and quality of life by comparing it with a standard supportive group psychotherapy.
Full Description
As per Brief Summary
Eligibility Criteria
Inclusion Criteria:
21 years of age or older;
English speaking;
Stage III or IV solid-tumor or Non-Hodgkin's Lymphoma;
Receiving ambulatory care at Memorial Sloan-Kettering Cancer Center in New York City;
Exclusion Criteria:
Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a group-format intervention;
Presence of cognitive impairment disorder, such as delirium or dementia that is sufficient, in the investigator's opinion, to preclude meaningful participation and/or informed consent;
Karnofsky Performance Rating Scale below 50 or physical limitations or illness severity sufficient to preclude participation in outpatient group psychotherapy.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10021, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.